Calcium supplementation during pregnancy may significantly reduce risk of preeclampsia

Written By :  Dr. Shravani Dali
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2023-12-06 06:00 GMT   |   Update On 2023-12-06 07:05 GMT

Calcium supplementation during pregnancy may significantly reduce the risk of preeclampsia and gestational hypertension suggests a new study published in the Current Problems in Cardiology.Pre-eclampsia and eclampsia are common causes of morbidity and mortality, especially in low-income countries. Reducing adverse outcomes associated with hypertensive disorders of pregnancy has been the...

Login or Register to read the full article

Calcium supplementation during pregnancy may significantly reduce the risk of preeclampsia and gestational hypertension suggests a new study published in the Current Problems in Cardiology.

Pre-eclampsia and eclampsia are common causes of morbidity and mortality, especially in low-income countries. Reducing adverse outcomes associated with hypertensive disorders of pregnancy has been the ultimate priority in recent years. We aim to evaluate the association between calcium supplements and preeclampsia and gestational hypertension risk among pregnant women.

A systematic literature search was performed in electronic databases from inception to 15th July 2023, including only randomized controlled trials. Odds ratio (OR) were, and their corresponding 95% confidence interval (95% CI).

Results

A total of 26 studies with 19969 patients (9,968 patients with calcium supplements and 10,001 patients with placebo group) were included in the analysis. The Pooled analysis of primary outcome shows that calcium supplements reduce the risk of preeclampsia by 44% (OR, 0.56(95%CI: 0.45-0.70), P<0.001), and reduce the risk of gestational hypertension by 20% (OR, 0.80(95%CI: 0.70-0.91), P<0.001) compared to placebo. There was a trend of lower incidence of preterm delivery (OR, 0.88 (95%CI: 0.71-1.09), P=0.23), labor induction (OR, 0.90 (95%CI: 0.78-1.03), P=0.13), small gestational age (OR, 0.70 (95% CI:0.37, 1.32), P = 0.27), low birth weight (OR, 0.90 (95%CI: 0.78-1.03), P=0.13), perinatal mortality (OR, 0.88 (95%CI: 0.71-1.08), P=0.22), and maternal mortality (OR, 0.48 (95%CI: 0.12-1.84), P=0.28) among calcium supplementation group compared with the placebo group, however not able to reach statistical significant.

This study shows that calcium supplements are associated with a significant reduction in the risk of preeclampsia and gestational hypertension and a trend toward better maternal and fetal-related outcomes.

Reference:

Vikash Jaiswal, Amey Joshi, Mayank Jha, Muhammed Hanif, Ananya Arora, Shiva Gupta, Maitri Shah, Novonil Deb, Song Peng Ang, Savvy Aujla, Nirmit Patel, Ayesha Habib, Gayatri Ghadvaje. Association between calcium supplementation and gestational hypertension, and preeclampsia: A Meta-analysis of 26 randomized controlled trials, Current Problems in Cardiology, 2023, 102217, ISSN 0146-2806. https://doi.org/10.1016/j.cpcardiol.2023.102217.

(https://www.sciencedirect.com/science/article/pii/S0146280623006345)

Tags:    
Article Source : Current Problems in Cardiology

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News